Topical corticosteroids
Executive Summary
On Jan. 26-28, FDA's Dallas District Lab will hold workshops on the setup, operating procedure and application of the in vitro drug release procedure mentioned in the "Interim Guidance Topical Corticosteroids: In Vivo Bioequivalence and In Vitro Release Methods', which issued July 1, 1992. Contact Helga Bryson, Office of Generic Drugs, (301) 594-0340